Yıl: 2014 Cilt: 23 Sayı: 3 Sayfa Aralığı: 223 - 228 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

The role of neutrophil gelatinase-associated lipocalin (ngal) in the determination of contrast-ınduced nephropathy in patients undergoing coronary angiography

Öz:
AMAÇ: Kontrast madde nefropatisi; diğer nedenler ekarte edildikten sonra kontrast ajanın uygulan- masını takiben gelişen bir akut böbrek hasarı tablosudur. Çalışmamızda, klinik pratikte sıklığı giderek artan ve kardiyak kateterizasyon yapılan olgularda önemli bir akut böbrek yetmezliği sebebi olan kont- rast madde nefropatisinin erken tanısında üriner NGAL(neutrophil gelatinase associated lipocalin)in yerini saptamayı amaçladık. GEREÇ ve YÖNTEMLER: Çalışmamıza, 1 Ocak 2011 ve 1 Mart 2011 tarihleri arasında elektif koroner anjiyografi uygulanan 100 olgu dahil edildi. Hastaların üriner NGAL seviyeleri için idrar örnekleri koroner anjiyografi yapıldıktan en geç 4 saat içinde alındı. BULGULAR: Koroner anjiyografiyi izleyen 48. saatte 8 hastanın kreatinin seviyeleri en az %25 artmıştı ve kontrast madde nefropatisi(KMN) tanısı konuldu. Bu 8 hastanın tamamında üriner NGAL değerleri kabul edilebilir sınır olan 100 ng/ml üzerindeydi.KMN gelişen hastaların 6sı kadın ve 2si erkekti. Tüm hastalarda hipertansiyon veya eşlik eden bir diğer kronik hastalık mevcuttu. SONUÇ: Anjiyografi sonrası KMN tanısı konvansiyonel metodla işlemden 48 saat sonra kreatinin düzeyi bakılarak konulabilmektedir fakat üriner NGAL düzeyi bakılması tanı ve tedaviyi hızlandırabilir ve hastanede kalma süresini kısaltabilir.
Anahtar Kelime:

Konular: Cerrahi

Koroner anjiyografi yapılan hastalarda kontrast madde nefropatisini saptamada nötrofil jelatinaz ilişkili lipokalinin yeri

Öz:
OBJECTIVE: Contrast-induced nephropathy (CIN) is the acute kidney injury developing following he administration of contrast agent after all other reasons are excluded. We aimed to determine the ole of NGAL in the urine for early diagnosis of contrast-induced nephropathy, as the disorder is an mportant reason of acute renal failure in cases subject to cardiac catheterization clinical practice, and he frequency is increasing. MATERIAL and METHODS: One hundred cases undergoing elective coronary angiography between he dates of January 1st 2011 and March 1st 2011 were included in the study. Urine samples of the patients were taken maximum 4 hours after the coronary angiography to check the urinary NGAL level. RESULTS: The creatinine level had increased 25% in 8 patients at the 48th hour following angiography and this was accepted as CIN. Using a cutoff value of 100 ng/ml, urinary NGAL levels were found to elevated in these 8 patients, consisting of 6 females and 2 males. All them had hypertension (HT) by tself or with other accompanying diseases. CONCLUSION: The CIN diagnosis can be made with the conventional method of measuring the level of creatinine in the blood 48 hours after surgery but using the urinary NGAL method can fasten the diagnosis and treatment and also can shorten hospital stays.
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Spinler SA, Goldfarb S: Nephrotoxicity of contrast media after cardiac angiography: Pathogenesis, clinical course, and preventive measures including the role of low osmolality contrast media. Ann Pharmacother 1992; 26: 56-64
  • 2. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT: Hospital-acquired renal insufficiency: A prospective study. Am J Med 1983; 74: 243-248
  • 3. Quader MA, Sawmiller C, Sumpio BA: Contrast-induced nephropathy: Review of incidence and pathophysiology. Ann Vasc Surg 1998; 12: 612-620
  • 4. Hill JA, Lambert CR, Pepine CJ: Radiographic contrast agents. In Pepine CJ, Hill JA, Lambert CR (eds), Diagnostic and Therapeutic Cardiac Catheterization. (2nd ed). Baltimore: Williams & Wilkins, 1994; 192
  • 5. Younathan CA, Kaude JV, Cook MD, Shaw GS, Peterson JC: Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis. Am J Roentgenol 1994; 163: 969-971
  • 6. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr: Incidence and prognostic importance of acute renal failure after percutaneous intervention. Circulation 2002; 105: 2259-2264
  • 7. Alharazy SM, Kong N, Saidin R, Gafor AH, Maskon O, Mohd M, Zakaria SZ: Neutrophil gelatinase-associated lipocalin as an early marker of contrast-induced nephropathy after coronary angiography. Angiology 2014; 65(3): 216-223
  • 8. Ronco C: N-GAL: Diagnosing AKI as soon as possible. Crit Care 2007; 11(6): 173
  • 9. Malyszko J, Bachorzewska-Gajewska H, Poniatowski B, Malyszko JS, Dobrzycki S: Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stabil angina and without severe chronic kidney disease. Ren Fail 2009; 31: 910-919
  • 10. Porter GA: Contrast-associated nephropathy. Am J Cardiol 1989; 64: 22E-26E
  • 11. Cavalier E, Saarbach D, Bekaert A, Carlisi A, Chapelle J, Delanaye P: Analytical Validation of the Abbott Architect urine NGAL. Clin Chem 2010; 56(Suppl 6):A96
  • 12. Gabbard W, Milbrandt EB, Kellum JA: NGAL: An emerging tool for predicting severity of AKI is easily detected by a clinical assay. Critical Care 2010; 14: 318
  • 13. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury following cardiac surgery. Lancet 2005; 365: 1231-1238
  • 14. Xu S, Venge P: Lipocalins as biomarkers of disease. Biochim Biophys Acta 2000; 1482: 298-307
  • 15. Schmidt-Ott KM, Mori K, Li JY, Kalandadze A, Cohen DJ, Devarajan P, Barasch J: Dual action of neutrophil gelatinaseassociated lipocalin. J Am Soc Nephrol 2007; 18: 407-413
  • 16. Liu Q, Nilsen-Hamilton M: Identification of a new acute phase protein. J Biol Chem 1995; 270: 22565-22570
  • 17. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S: Neutrophil gelatinase-associated lipocalin(NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography. Nephrol Dial Transplant 2007; 22: 295-296
  • 18. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Pawlak K, Mysliwiec M, Lawnicki S, Szmitkowski M, Dobrzycki S: Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values? Kidney Blood Press Res 2007; 30: 408-415
  • 19. Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL): A new marker of kidney disease. Scand J Clin Lab Invest Suppl 2008; 241: 89-94
  • 20. Hemdahl AL, Gabrielsen A, Zhu C, Eriksson P, Hedin U, Kastrup J, Thorén P, Hansson GK: Expression of NGAL in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol 2006; 26: 136-142
  • 21. Mehran R, Aymong ED, Dangas G, Abizaid AS, Abizaid AA, Mintz GS, Adamian MG, Moussa I, Lansky AJ, Stone GW, Moses JW, Leon MB: A risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 2003; 41(Suppl A): 37A
  • 22. Ogi M, Iwase N, Kitamura T, Sawanobori T, Fujimaki S, Kuramochi M, Fujita T, Yokoyama H, Tomosugi N, Takabatake T: Risk factors for contrast nephropathy in diabetic patients undergoing cardioangiography. Nippon Jinzo Gakkai Shi 1993; 35: 161-170
  • 23. Davidson C, Stacul F, McCullough PA, Tumlin J, Adam A, Lameire N, Becker CR; CIN Consensus Working Panel: Contrast medium use. Am J Cardiol 2006; 98: 42-58
  • 24. Gupta RK, Kapoor A, Tewari S, Sinha N, Sharma RK: Captopril for prevention of contrast-induced nephropathy in diabetic patients: A randomised study. Indian Heart J 1999; 51: 521-526
  • 25. Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, Lansky AJ, Moussa I, Stone GW, Moses JW, Leon MB, Mehran R: Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005; 95: 13-19
  • 26. Toprak O, Cirit M, Bayata S, Yeşil M, Aslan SL: Koroner anjiyografi yapılan hastalarda işlem öncesi verilen kaptoprilin kontrast madde nefropatisi üzerine etkisinin arastırılması. Anadolu Kardiyol Derg 2003; 3: 98-103
  • 27. Gomes AS, Baker JD, Martin-Paredero V, Dixon SM, Takiff H, Machleder HI, Moore WS: Acute renal dysfunction after major arteriography. Am J Roentgenol 1985; 145: 1249-1253
  • 28. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality: A cohort analysis. JAMA 1996 ;275: 1489-1494
  • 29. Wenhua L, Dongye L, Tongda X, Yanbin Z, Hong Z, Fei H: The value of urinary NGAL on the early diagnosis of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Heart 2011; 97: A150
APA GÜLOĞLU ÇOLAK C, ALP A, ŞAHİN S, ÖZDOĞAN Ö, KURTULMUŞ Y, Çolak H, TANRISEV M, TEKÇE H (2014). The role of neutrophil gelatinase-associated lipocalin (ngal) in the determination of contrast-ınduced nephropathy in patients undergoing coronary angiography. , 223 - 228.
Chicago GÜLOĞLU ÇOLAK Canan,ALP ALPER,ŞAHİN SEVNAZ,ÖZDOĞAN Ömer,KURTULMUŞ Yusuf,Çolak Hülya,TANRISEV Mehmet,TEKÇE Hikmet The role of neutrophil gelatinase-associated lipocalin (ngal) in the determination of contrast-ınduced nephropathy in patients undergoing coronary angiography. (2014): 223 - 228.
MLA GÜLOĞLU ÇOLAK Canan,ALP ALPER,ŞAHİN SEVNAZ,ÖZDOĞAN Ömer,KURTULMUŞ Yusuf,Çolak Hülya,TANRISEV Mehmet,TEKÇE Hikmet The role of neutrophil gelatinase-associated lipocalin (ngal) in the determination of contrast-ınduced nephropathy in patients undergoing coronary angiography. , 2014, ss.223 - 228.
AMA GÜLOĞLU ÇOLAK C,ALP A,ŞAHİN S,ÖZDOĞAN Ö,KURTULMUŞ Y,Çolak H,TANRISEV M,TEKÇE H The role of neutrophil gelatinase-associated lipocalin (ngal) in the determination of contrast-ınduced nephropathy in patients undergoing coronary angiography. . 2014; 223 - 228.
Vancouver GÜLOĞLU ÇOLAK C,ALP A,ŞAHİN S,ÖZDOĞAN Ö,KURTULMUŞ Y,Çolak H,TANRISEV M,TEKÇE H The role of neutrophil gelatinase-associated lipocalin (ngal) in the determination of contrast-ınduced nephropathy in patients undergoing coronary angiography. . 2014; 223 - 228.
IEEE GÜLOĞLU ÇOLAK C,ALP A,ŞAHİN S,ÖZDOĞAN Ö,KURTULMUŞ Y,Çolak H,TANRISEV M,TEKÇE H "The role of neutrophil gelatinase-associated lipocalin (ngal) in the determination of contrast-ınduced nephropathy in patients undergoing coronary angiography." , ss.223 - 228, 2014.
ISNAD GÜLOĞLU ÇOLAK, Canan vd. "The role of neutrophil gelatinase-associated lipocalin (ngal) in the determination of contrast-ınduced nephropathy in patients undergoing coronary angiography". (2014), 223-228.
APA GÜLOĞLU ÇOLAK C, ALP A, ŞAHİN S, ÖZDOĞAN Ö, KURTULMUŞ Y, Çolak H, TANRISEV M, TEKÇE H (2014). The role of neutrophil gelatinase-associated lipocalin (ngal) in the determination of contrast-ınduced nephropathy in patients undergoing coronary angiography. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, 23(3), 223 - 228.
Chicago GÜLOĞLU ÇOLAK Canan,ALP ALPER,ŞAHİN SEVNAZ,ÖZDOĞAN Ömer,KURTULMUŞ Yusuf,Çolak Hülya,TANRISEV Mehmet,TEKÇE Hikmet The role of neutrophil gelatinase-associated lipocalin (ngal) in the determination of contrast-ınduced nephropathy in patients undergoing coronary angiography. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi 23, no.3 (2014): 223 - 228.
MLA GÜLOĞLU ÇOLAK Canan,ALP ALPER,ŞAHİN SEVNAZ,ÖZDOĞAN Ömer,KURTULMUŞ Yusuf,Çolak Hülya,TANRISEV Mehmet,TEKÇE Hikmet The role of neutrophil gelatinase-associated lipocalin (ngal) in the determination of contrast-ınduced nephropathy in patients undergoing coronary angiography. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, vol.23, no.3, 2014, ss.223 - 228.
AMA GÜLOĞLU ÇOLAK C,ALP A,ŞAHİN S,ÖZDOĞAN Ö,KURTULMUŞ Y,Çolak H,TANRISEV M,TEKÇE H The role of neutrophil gelatinase-associated lipocalin (ngal) in the determination of contrast-ınduced nephropathy in patients undergoing coronary angiography. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi. 2014; 23(3): 223 - 228.
Vancouver GÜLOĞLU ÇOLAK C,ALP A,ŞAHİN S,ÖZDOĞAN Ö,KURTULMUŞ Y,Çolak H,TANRISEV M,TEKÇE H The role of neutrophil gelatinase-associated lipocalin (ngal) in the determination of contrast-ınduced nephropathy in patients undergoing coronary angiography. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi. 2014; 23(3): 223 - 228.
IEEE GÜLOĞLU ÇOLAK C,ALP A,ŞAHİN S,ÖZDOĞAN Ö,KURTULMUŞ Y,Çolak H,TANRISEV M,TEKÇE H "The role of neutrophil gelatinase-associated lipocalin (ngal) in the determination of contrast-ınduced nephropathy in patients undergoing coronary angiography." Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, 23, ss.223 - 228, 2014.
ISNAD GÜLOĞLU ÇOLAK, Canan vd. "The role of neutrophil gelatinase-associated lipocalin (ngal) in the determination of contrast-ınduced nephropathy in patients undergoing coronary angiography". Türk Nefroloji Diyaliz ve Transplantasyon Dergisi 23/3 (2014), 223-228.